RecruitingNot ApplicableNCT06280300
Multi-disciplinary Care for Brain Metastases
Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases
Sponsor
University of Vermont Medical Center
Enrollment
40 participants
Start Date
Nov 16, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patients of all genders must be at least 18 years of age.
- Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
- Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
- Patients must be able to complete questionnaires in English.
- Patients must have the ability to provide informed consent.
Exclusion Criteria2
- Patients who are \< 18 years of age are not eligible.
- Patients who are Pregnant are not eligible.
Interventions
OTHERhealth services intervention
Health services intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06280300
Related Trials
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
NCT055598531 location
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
NCT057895891 location
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT041972971 location
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NCT0512423610 locations
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
NCT060473796 locations